GSK
LIVE

Serial Number

97446056

Owner

SmithKline Beecham Limited

Attorney

Christopher M. Hanes

First Use Date

Jun 9, 2022

Filing Date

Jun 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GSK Trademark

Serial Number: 97446056

GSK is a trademark filed by SmithKline Beecham Limited on June 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

SmithKline Beecham Limited

980 Great West Road
Brentford, Middlesex TW89GS

Entity Type: 99

Trademark Details

Filing Date

June 7, 2022

Registration Date

Not Registered

First Use Anywhere

June 9, 2022

First Use in Commerce

June 9, 2022

Published for Opposition

August 8, 2023

Goods & Services

Educational services, namely, conducting classes in the field of pharmaceutical, diagnostic, vaccines, proprietary medicines, health, medical and skin care industries; educational services, namely, conducting seminars regarding health and health awareness and distributing course material in connection therewith; conducting, organizing and arranging conferences, seminars and exhibitions for educational purposes in the field of medicine, health and wellness; publication of documents recorded on electronic storage media and on the internet in the field of scientific, medical diagnostic and technical laboratory matters and for research; training in the operation of scientific, surgical and medical devices and apparatus; publishing and issuing of scientific papers in the field of pharmaceuticals, diagnostic, vaccines, proprietary medicines, health, medical and skin care; provision of information, consultancy and advisory services relating to any of the aforesaid services

Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; provision of information, consultancy and advisory services relating to any of the aforesaid services

Advertising, marketing and promotional services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; the provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, healthcare products through an on-line computer network; distribution of advertising, marketing and promotional material

Scientific research for medical purposes in the field of pharmaceuticals, vaccines; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; scientific research consulting; medical laboratory services; Providing medical and scientific research information; medical and pharmacological research services; software development, programming and implementation; provision of information, consultancy and advisory services relating to any of the aforesaid services

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation; Pharmaceutical preparations for the treatment of viral, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Aug 3, 2026 SUPC
USE AMENDMENT FILED
Jul 31, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 31, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 17, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jul 17, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 16, 2026 AITU
SOU EXTENSION 5 FILED
Mar 6, 2026 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 10, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 10, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 12, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 12, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 12, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 23, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 11, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 11, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 6, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 6, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 6, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jul 5, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 30, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 2, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2022 NWOS
NEW APPLICATION ENTERED
Jun 10, 2022 NWAP